Overview The Ministry of Science & Technology has unveiled a suite of initiatives to reshape India’s biotechnology sector. Central to this effort is the launch of the country’s first Biofoundry Network , rolled out under the BioE3 Policy . The overarching goal is to achieve a **$300 billion bio‑economy by 2030**. Key Developments Establishment of 15 BIRAC‑supported bio‑enabler facilities across the country, offering shared infrastructure to start‑ups, SMEs, industries and academia. Launch of the Biopharma SHAKTI scheme with a **₹10,000 crore** outlay over five years. Continuation of the Biotechnology Ignition Grant (BIG) programme, which has supported >1,000 startups to date. Recognition of India’s bio‑economy value at **$195.3 billion in 2025**, marking an **18 % annual growth** from the previous year. Important Facts The bio‑enabler facilities will cater to sectors such as microbial biomanufacturing, sustainable agriculture, smart proteins, functional foods, precision biotherapeutics, marine biotechnology, carbon capture and next‑generation cell and gene therapies. They aim to reduce import dependence, generate skilled employment, and position India as a global leader in clean, green technologies. Since its inception in 2012, the BIG programme has: Supported **1,000+** early‑stage biotech startups. Facilitated the development of **200+** products/technologies. Enabled **800+** IP filings and mobilised **₹3,500+ crore** in follow‑on funding. Created **3,500+** skilled jobs and empowered **250+** women entrepreneurs. UPSC Relevance These initiatives intersect multiple GS papers: GS3 – Economy: The push for a $300 bn bio‑economy illustrates the role of high‑technology sectors in GDP growth, export diversification and employment generation. GS1 – Indian Heritage & Culture: Biotechnology’s impact on agriculture and health ties into India’s self‑reliance narrative. GS4 – Ethics & Integrity: Public‑private partnerships like BIRAC raise questions on governance, IP rights and equitable access. Way Forward To translate the ambitious targets into tangible outcomes, the government should: Strengthen coordination between the DBT , state governments and industry clusters. Facilitate faster regulatory clearances for bio‑products, especially in the health and agriculture domains. Expand skill‑development programmes to meet the demand for specialised biotech manpower. Encourage export‑oriented R&D to convert domestic innovations into global market offerings. Collectively, these steps will help India achieve a resilient, self‑sufficient bio‑economy and bolster its standing in the global biotechnology arena.